Capere DVT Thrombectomy System | Vascular Medcure

OUR MISSION

is to Design and Develop Advanced Endovascular Devices for Optimal Extraction of Thrombus from the vascular system

60,000-100,000 Americans die of DVT/PE

0 to 30% of people will die within one month of diagnosis

Sudden death is the first symptom in about one-quarter (25%) of people who have a PE

Disease Background

our device technology

A Novel Thrombectomy System

Vascular Medcure has developed a novel thrombectomy system for the treatment of DVT, PE1, and thrombosed AV Graft1. The CAPERE® Thrombectomy System features a mechanical retrieval method with no need for thrombolytic drugs, aspiration or capital equipment. The system allows complete retrieval of soft emboli and thrombi while providing distal and proximal protection.

1 PE & AV Graft Device not available for sale

See Our Products

our leaders

Executive Management Team

CEO

Samuel Shaolian

Co-Founder & VP

Duy Nguyen

Co-Founder & VP

Thanh Nguyen

Learn More About Our Team

We Want to Hear from You

Tel: 657-549-5175

Fax: 714-399-0168

Address:

1500 South Sunkist Street, Suite H, Anaheim, CA 92806

The CAPERE® Thrombectomy System is protected by US Patents No. 9,579116, 9,636,206, 9,744,024, 9,844,386, 9,999,493, 10,070879, 10,143,482, 10,238,482, 10,376,275 and other pending patent applications. CAPERE® is a registered trademark of Vascular Medcure, Inc.